60 results on '"Eberhardt, Christiane S"'
Search Results
2. Contributors
3. Immune escape of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1 after vaccination, infection and hybrid immunity
4. Mise à jour des vaccins chez les personnes âgées
5. Paediatric acute respiratory distress syndrome
6. Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonates
7. Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19
8. T Cell Receptor Repertoire Profiling Reveals Breadth of Cellular Responses Against Sars-Cov-2 after Natural Infection and Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients
9. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
10. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
11. Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
12. Contrasting behavior between the three human monocyte subsets in dengue pathophysiology
13. Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis
14. A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project
15. Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
16. Gynécologie-obstétrique. Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021
17. Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
18. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
19. Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients
20. Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy
21. Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study
22. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity
23. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
24. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms
25. Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer
26. SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1
27. Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients
28. Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines
29. Coronavirus disease 2019 vaccination in transplant recipients
30. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
31. Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection
32. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
33. The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody Transfer
34. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
35. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association With Viral Load, Independent of Symptoms
36. SARS-CoV2- infection as a trigger of humoral response against apolipoprotein A-1
37. Faudra-t-il vacciner les enfants contre le Covid-19 ?
38. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series
39. Paradoxes and Uncertainties of Immunomodulatory Treatments in the Fight Against Coronavirus Disease 2019
40. Defining HPV-specific B cell responses in patients with head and neck cancer
41. Challenges and issues of SARS-CoV-2 pool testing
42. Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy
43. Influenza Immunization in the Context of Preexisting Immunity
44. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination
45. Antibody Persistence in the Six Months Following SARS-CoV-2 Infection Among Hospital Workers
46. Understanding the immunology of the Zostavax shingles vaccine
47. Abstract 526: Tumor-draining lymph node irradiation reduces tumor-infiltrating stem-like CD8+T-cells and abrogates the abscopal effect
48. Abstract 526: Tumor-draining lymph node irradiation reduces tumor-infiltrating stem-like CD8+T-cells and abrogates the abscopal effect
49. Characterization of Virus-specific Immune Response During Varicella Zoster Virus Encephalitis in a Young Adult
50. Cautious Interpretation of Optimal Timing of Maternal Pertussis Immunization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.